Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Dabur gets new CEO,...

    Dabur gets new CEO, Mohit Malhotra to take charge from April

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-02-02T09:30:47+05:30  |  Updated On 2 Feb 2019 9:30 AM IST
    Dabur gets new CEO, Mohit Malhotra to take charge from April

    As a result of this process, Mr Mohit Malhotra was found to be suitable as a successor to Mr Duggal. Therefore, on the recommendation of the Nomination and Remuneration Committee, the Board today approved the appointment of Mr Malhotra as the new Chief Executive Officer of Dabur India Ltd."


    New Delhi: The Dabur India Ltd board today approved the appointment of Mr Mohit Malhotra as the company's New Chief Executive Officer with effect from April 1, 2019. Mr Malhotra, who is currently the CEO of the company's India business, will succeed current CEO, Mr Sunil Duggal.


    Announcing the appointment, Dabur India Ltd Chairman Dr Anand C Burman said: "During the last few years, the Board of Directors of the Company had undertaken a Succession Planning exercise to identify the successor to take over the responsibility from Mr Sunil Duggal, who has been the Dabur India Ltd CEO since 2002. Mr Duggal was entrusted with the responsibility of ensuring a smooth transition.


    As a result of this process, Mr Mohit Malhotra was found to be suitable as a successor to Mr Duggal. Therefore, on the recommendation of the Nomination and Remuneration Committee, the Board today approved the appointment of Mr Malhotra as the new Chief Executive Officer of Dabur India Ltd."


    "I, on behalf of the Dabur Board, thank Mr Sunil Duggal for his invaluable contribution of over 24 years with the organization, including 17 years as the CEO. I also wish Mr Mohit Malhotra all the best, and we are confident that under his leadership, the Company will continue to grow," Dr Burman added.


    Mr Malhotra, who was also appointed as a Whole-Time Director of the Company with effect from January 31, 2019, will work as CEO-Designate till March 31, 2019, under the guidance of Mr Duggal. Consequently, Mr Duggal will hold the position of CEO till the end of the financial year 2018-19 and will remain a WholeTime Director till May 15, 2019. Mr Duggal will then continue as a Non-Executive Director till July 30, 2020.


    Mr Malhotra, 49 years old, is a Management Graduate from Pune University and holds an Executive Masters in International Business from Indian Institute of Foreign Trade, New Delhi. He joined Dabur as a Management Trainee in 1994 and handled key assignments in Marketing and Sales, besides being CEO of Dabur International, based out of Dabur, before taking charge as the CEO-lndia Business in his current position.


    Also Read: Dabur plans a subscription-based model for ayurvedic medicines

    CEOchief executive officerDabur IndiaDr Anand C BurmanIndiainvaluable contributionmatter of prideMohit MalhotraSunil Duggal

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok